HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias H Thomas Selected Research

Therapeutics

1/2020Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias H Thomas Research Topics

Disease

5Ankylosing Spondylitis
06/2020 - 01/2018
4Rheumatoid Arthritis
06/2020 - 01/2018
4Psoriatic Arthritis
06/2020 - 01/2018
1Drug-Related Side Effects and Adverse Reactions
01/2018
1Necrosis
01/2018

Drug/Important Bio-Agent (IBA)

4golimumabFDA Link
06/2020 - 01/2018
2Tumor Necrosis Factor InhibitorsIBA
01/2020 - 01/2019
1Therapeutic UsesIBA
01/2018

Therapy/Procedure

1Therapeutics
01/2020